Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × peginterferon alfa-2a × 30 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Specimen Handling 363 pembrolizumab 303 Magnetic Resonance Spectroscopy 303 Biopsy 231 Carboplatin 211 Cyclophosphamide 195 Cisplatin 171 Paclitaxel 157 Nivolumab 144 Gemcitabine 132 Radiotherapy 120 venetoclax 119 Bevacizumab 112 Dexamethasone 108 fludarabine 96 Rituximab 90 Fluorouracil 90 Pemetrexed 88 Oxaliplatin 88 Doxorubicin 86 durvalumab 85 Docetaxel 83 atezolizumab 80 Radiation 80 Prednisone 79 Lenalidomide 76 Ipilimumab 69 X-Rays 66 Leucovorin 66 Capecitabine 66

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07288112 2026-02-23

DOC1021 Dendritic Cell Immunotherapy for Refractory Melanoma

Diakonos Oncology Corporation

Phase 1/2 Recruiting

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡